Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Provides Access for SureFISH Probes to BioDiscovery Customers

NEW YORK (GenomeWeb News) – Agilent Technologies today announced a deal with BioDiscovery allowing that firm's customers access to Agilent SureFISH probes directly from BioDiscovery's Nexus software.

The deal allows researchers who use different cytogenetic microarray platforms to now quickly identify aberrations with Nexus and to immediately identify and link to available oligonucleotide-based fluorescent in situ hybridization probes for follow-up studies, Agilent said.

Financial and other terms of the deal were not disclosed.

SureFISH probes are designed for specific, non-repetitive regions of the genome and allow scientists to detect repetitive and aberrant regions as small as 50 kb. The probes reduce the hybridization time to as little as four hours, Agilent said.

BioDiscovery's Nexus Copy Number software is for analysis and visualization of copy number variations from comparative genomic hybridization arrays, single-nucleotide polymorphism arrays, and next-generation sequencing data.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.